A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy
Min Sun, Xiaoxiao Liu, Lingyun Xia, Yuying Chen, Li Kuang, Xinsheng Gu, Tian Li
Topics & Concepts
OncologyBreast cancerProportional hazards modelAnthracyclineReceiver operating characteristicTaxaneInternal medicineUnivariateNomogramMedicineSurvival analysisHazard ratioCancerStage (stratigraphy)Multivariate statisticsBiologyComputer scienceMachine learningConfidence intervalPaleontologyCancer-related molecular mechanisms researchCircular RNAs in diseasesRNA modifications and cancer